Unopposed Zantac MDL Motion Subject Of Jan. 30 Hearing

Mealey's (January 8, 2020, 9:31 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation on Dec. 19 announced that it will hear arguments on Jan. 30 on whether to centralize 15 federal lawsuits alleging injuries and economic loss from the over-the-counter heartburn drug Zantac (In Re:  Zantac [Ranitidine] Products Liability Litigation, MDL Docket No. 2924, JPMDL)....

Related Sections